SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The conflicts between parallel trade and product access and innovation: the case of pharmaceuticals
0 references·11 citing·45 second hop
The conflicts between parallel trade and product access and innovation: the case of pharmaceuticals (1998)The conflicts between parallel trade and …Intellectual Property Exhaustion and Parallel Imports of Pharmaceuticals: A Comparative and Critical Review (2020)Intellectual Property Exhaust…How should firms deal with counterfeiting? (2014)How should firms deal with co…Moral Psychology and the Intuition that Pharmaceutical Companies Have a ‘Special’ Obligation to Society (2013)Moral Psychology and the Intu…Product counterfeiting, non‐consensual acquisition of technology and new product development (2007)Product counterfeiting, non‐c…Patents and Access to Antiretroviral Medicines in Vietnam after World Trade Organization Accession (2007)Patents and Access to Antiret…Intellectual Property Rights, Parallel Imports and Strategic Behavior (2007)Intellectual Property Rights,…The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health (2005)The WTO Medicines Decision: W…WTO DECISION ON IMPLEMENTATION OF PARAGRAPH 6 OF THE DOHA DECLARATION ON THE TRIPS AGREEMENT AND PUBLIC HEALTH: A SOLUTION TO THE ACCESS TO ESSENTIAL MEDICINES PROBLEM? (2004)WTO DECISION ON IMPLEMENTATIO…How Do Patents And Economic Policies Affect Access To Essential Medicines In Developing Countries? (2004)How Do Patents And Economic P…Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa? (2001)Do Patents for Antiretroviral…Broad‐Based Compulsory Licensing of Pharmaceutical Technologies (2001)Broad‐Based Compulsory Licens…The Economics of Imperfect Competition. (1933)The Economics of Imperfect Competition. (1934)Pricing to Market when the Exchange Rate Changes (1986)Non-homothetic preferences, parallel imports and the extensive margin of international trade (2010)Retailers as agents and the limits of parallel trade (2014)International arbitrage and the extensive margin of trade between rich and poor countries* (2017)Economic Action and Social Structure: The Problem of Embeddedness (1985)Conceptualizing, Measuring, and Managing Customer-Based Brand Equity (1993)Economic Action and Social Structure: The Problem of Embeddedness (2002)Legal system uncertainty and FDI attraction in Southeast Asia (2015)Systematic review: resilience enablers to combat counterfeit medicines (2018)Anti-counterfeiting advertisements for luxury brands in the post pandemic era: Roles of message type, visual presentation mode, and self-construal (2023)Intellectual Property Rights in the Global Economy (2000)Drug development for neglected diseases: a deficient market and a public-health policy failure (2002)The price of innovation: new estimates of drug development costs (2003)The Political Economy of AIDS Treatment: Intellectual Property and the Transformation of Generic Supply (2007)Global Health Governance (2008)Defining Health Diplomacy: Changing Demands in the Era of Globalization (2011)An evolutionary theory of economic change (1982)An Evolutionary Theory of Economic Change. (1983)An exploratory analysis of counterfeiting strategies (2015)Counterfeiting: addressing mitigation and resilience in supply chains (2018)Moving from reverse engineering to disruptive innovation in emerging markets: The importance of knowledge creation (2023)Integrating public health concerns into patent legislation in developing countries (2000)Intellectual Property Rights in the Global Economy (2001)Intellectual property rights, the WTO and developing countries: the TRIPS agreement and policy options (2001)Trips, Pharmaceuticals, Developing Countries, and the Doha 'Solution' (2002)Reframing the issue: the WTO coalition on intellectual property and public health, 2001 (2006)Global pharmaceutical regulation: the challenge of integration for developing states (2016)A Treatise of Human Nature (1739)Corporate Social Responsibility (1999)Strategy and society: the link between competitive advantage and corporate social responsibility (2007)How Do Self-Values Play a Role In Consumers’ Perception of CSR Advertising? (2017)Cure or Sell: How Do Pharmaceutical Industry Marketers Combine Their Dual Mission? An Approach Using Moral Dissonance (2020)Understanding ethical/unethical behavior in pharmaceutical companies: a literature review (2020)25 years of the WHO essential medicines lists: progress and challenges (2003)Global Trade and Public Health (2005)The Health Impact Fund: incentives for improving access to medicines (2010)Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis (2012)Access to Essential Drugs in Poor Countries (1999)Compulsory Licensing Provisions Under the TRIPs Agreement: Balancing Pills and Patents (2000)The Role of Technological Change in Green Growth (2012)Trademark Law: An Economic Perspective (1987)The World Intellectual Property Organization (2012)International Institute for Sustainable Development (2014)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2005The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health193 cited
  • 2004How Do Patents And Economic Policies Affect Access To Essential Medicines In Developing Countries?184 cited
  • 2001Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa?169 cited
  • 2004WTO DECISION ON IMPLEMENTATION OF PARAGRAPH 6 OF THE DOHA DECLARATION ON THE TRIPS AGREEMENT AND PUBLIC HEALTH: A SOLUTION TO THE ACCESS TO ESSENTIAL MEDICINES PROBLEM?127 cited
  • 2007Product counterfeiting, non‐consensual acquisition of technology and new product development43 cited
  • 2014How should firms deal with counterfeiting?35 cited
  • 2013Moral Psychology and the Intuition that Pharmaceutical Companies Have a ‘Special’ Obligation to Society20 cited
  • 2007Patents and Access to Antiretroviral Medicines in Vietnam after World Trade Organization Accession17 cited
  • 2007Intellectual Property Rights, Parallel Imports and Strategic Behavior17 cited
  • 2020Intellectual Property Exhaustion and Parallel Imports of Pharmaceuticals: A Comparative and Critical Review9 cited
  • 2001Broad‐Based Compulsory Licensing of Pharmaceutical Technologies9 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work